Comment
|
GSK3beta is activated by amyloid beta peptide and phosphorylates APP.
|
Formal Description Interaction-ID: 419
|
increases_phosphorylation of
activated by amyloid beta peptide
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
APP
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB02235
|
|
Drugbank
DB02235
|
|
|
|
Comment
|
GSK3B phosphorylates APC.
|
Formal Description Interaction-ID: 420
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
IRS1 is phosphorylated by GSK3B.
|
Formal Description Interaction-ID: 445
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
IRS1
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB08513
|
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENY ...
|
|
|
Comment
|
Myelin basic protein (MBP) is phosphorylated by GSK3B.
|
Formal Description Interaction-ID: 446
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
MAP1B and MAP2 also are phosphorylated by GSK3beta.
|
Formal Description Interaction-ID: 447
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
MAP1B and MAP2 also are phosphorylated by GSK3beta.
|
Formal Description Interaction-ID: 450
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
MAP2
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB01196
|
|
Drugbank
DB01196
|
|
|
|
Comment
|
Ninein (NN) is phosphorylated by GSK3B.
|
Formal Description Interaction-ID: 452
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3beta phosphorylates TAU / MAPT, which might contribute to neurofibrillary tangle formation.
|
Formal Description Interaction-ID: 453
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3beta phosphorylated c-Jun in vitro at three sites, including Thr-239, Ser-243, and Ser-249, and decreased its DNA binding activity.
|
Formal Description Interaction-ID: 454
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
JUN
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB00570
|
|
Drugbank
DB01029
|
|
Drugbank
DB01169
|
|
Drugbank
DB01029
|
|
|
|
Comment
|
Inhibition of GSK3B results in increased beta-catenin levels, its translocation to the nucleus, and facilitation of Tcf/Lef-mediated transcription.
|
Formal Description Interaction-ID: 455
|
by phosphorylating beta-catenin, targeting it for degradation;
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
CTNNB1
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB03904
|
|
Drugbank
DB03904
|
|
|
|
Comment
|
CEBPA is phosphorylated by GSK3b.
|
Formal Description Interaction-ID: 456
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
CREB is phosphorylated by GSK3b.
|
Formal Description Interaction-ID: 457
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
CREB1
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB00131
|
|
Drugbank
DB01183
|
|
Drugbank
DB00131
|
|
|
|
Comment
|
GSK3beta has an inhibitory effect on the activation of HSF-1.
|
Formal Description Interaction-ID: 458
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3beta can phosphorylate serine residues 38, 42, and 62, and threonine residue 58 within the transactivation domain of Myc, sites considered important for regulation of Myc transcriptional activity in vivo.
|
Formal Description Interaction-ID: 459
|
increases_phosphorylation of
the serine residues 38, 42, and 62, and threonine residue 58 within the transactivation domain of Myc.
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3B is regulated by Wnt signaling. In the absence of Wnt, GSK3B is complexed with Axin and APC and phosphorylates beta-catenin, targeting it for degradation.
|
Formal Description Interaction-ID: 463
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Phosphorylation of Axin by GSK3B stabilizes Axin.
|
Formal Description Interaction-ID: 464
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
AXIN1
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB04447
|
|
Drugbank
DB04447
|
|
|
|
Comment
|
GSK3B is complexed with Axin and APC and phosphorylates beta-catenin, targeting it for degradation.
|
Formal Description Interaction-ID: 465
|
interacts (colocalizes) with
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3B inhibited by phosphorylation at Ser9 could be reactivated with protein phosphatase 2A.
|
Formal Description Interaction-ID: 480
|
complex/PPI
Protein phosphatase 2A
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3B phosphorylates Thr-743 of the amyloid precursor protein.
|
Formal Description Interaction-ID: 481
|
increases_phosphorylation of
at Thr743
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
APP
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB02235
|
|
Drugbank
DB02235
|
|
|
|
Comment
|
GSK3B increases the cellular maturation of the amyloid precursor protein which may alter the production of the Alzheimer's disease-associated amyloid-beta (Abeta) peptide.
|
Formal Description Interaction-ID: 482
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
APP
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB02235
|
|
Drugbank
DB02235
|
|
|
|
Comment
|
GSK3B increases the cellular maturation of the amyloid precursor protein which may alter the production of the Alzheimer's disease-associated amyloid-beta (Abeta) peptide.
|
Formal Description Interaction-ID: 487
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Ser-9 of GSK3beta is phosphorylated (and thus inhibited) by protein kinase A.
|
Formal Description Interaction-ID: 491
|
increases_phosphorylation of
at Ser9
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
ACLY is phosphorylated by GSK3beta.
|
Formal Description Interaction-ID: 492
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3beta phosphorylates PPP1R2.
|
Formal Description Interaction-ID: 493
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Lithium, the primary therapeutic agent
for bipolar mood disorder, is a selective inhibitor of GSK3beta.
|
Formal Description Interaction-ID: 494
|
|
Drugbank entries
|
Show/Hide entries for
Lithium
or
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01356
|
|
Drugbank
DB01356
|
|
Drugbank
DB01356
|
|
Drugbank
DB01356
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3B phosphorylates eIF2B at Ser-540 and inhibits its activity.
|
Formal Description Interaction-ID: 495
|
increases_phosphorylation of
at Ser540, hereby inhibiting EIF2B5.
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3B phosphorylates eIF2B at Ser-540 and inhibits its activity.
|
Formal Description Interaction-ID: 496
|
by phosphorylation at Ser540.
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Maleimide and indirubin caused selective and
potent inhibition of GSK3beta.
|
Formal Description Interaction-ID: 593
|
drug/chemical compound
Maleimide
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Maleimide and indirubin caused selective and potent inhibition of GSK3beta.
|
Formal Description Interaction-ID: 594
|
drug/chemical compound
Indirubin
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Increased nuclear GSK3beta was induced by heat shock.
|
Formal Description Interaction-ID: 618
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Cell stressors can modulate the activity of GSK3beta, as both heat shock and oxidative stress can cause inhibition of GSK3beta.
|
Formal Description Interaction-ID: 620
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Protein kinase C alpha phosphorylates and inactivates GSK3B.
|
Formal Description Interaction-ID: 646
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
PRKCA
or
GSK3B
|
Drugbank
DB00144
|
|
Drugbank
DB00163
|
|
Drugbank
DB00144
|
|
Drugbank
DB00163
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Protein kinase C alpha phosphorylates and inactivates GSK3B.
|
Formal Description Interaction-ID: 647
|
|
Drugbank entries
|
Show/Hide entries for
PRKCA
or
GSK3B
|
Drugbank
DB00144
|
|
Drugbank
DB00163
|
|
Drugbank
DB00144
|
|
Drugbank
DB00163
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Protein kinase C beta phosphorylates and inactivates GSK3B.
|
Formal Description Interaction-ID: 648
|
increases_phosphorylation of
hereby inactivating GSK3B.
|
Drugbank entries
|
Show/Hide entries for
PRKCB
or
GSK3B
|
Drugbank
DB00163
|
|
Drugbank
DB01738
|
|
Drugbank
DB00163
|
|
Drugbank
DB01738
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Protein kinase C beta phosphorylates and inactivates GSK3B.
|
Formal Description Interaction-ID: 649
|
|
Drugbank entries
|
Show/Hide entries for
PRKCB
or
GSK3B
|
Drugbank
DB00163
|
|
Drugbank
DB01738
|
|
Drugbank
DB00163
|
|
Drugbank
DB01738
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Protein kinase C gamma phosphorylates and inactivates GSK3B.
|
Formal Description Interaction-ID: 650
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Protein kinase C gamma phosphorylates and inactivates GSK3B.
|
Formal Description Interaction-ID: 651
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Protein kinase C (gamma but not epsilon) phosphorylates and inactivates GSK3B.
|
Formal Description Interaction-ID: 652
|
NOT affects_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Protein kinase C (gamma but not epsilon) phosphorylates and inactivates GSK3B.
|
Formal Description Interaction-ID: 653
|
NOT decreases_activity of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Active AKT (phosphorylated at Ser-473 and Thr-308) reduces activity of GSK3B by phosphorylation of Ser-9.
|
Formal Description Interaction-ID: 671
|
protein modification
AKT1-phosSer473Thr308
increases_phosphorylation of
at Ser-9, hereby reducing the activity of GSK3B.
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Active AKT (phosphorylated at Ser-473 and Thr-308) reduces activity of GSK3B by phosphorylation of Ser-9.
|
Formal Description Interaction-ID: 672
|
protein modification
AKT1-phosSer473Thr308
by phosphorylation of GSK3B at Ser9
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Insulin-like growth factor-1 (IGF-1) inhibits GSK3B through increased Ser-9 phosphorylation in a PI3K-dependent manner.
|
Formal Description Interaction-ID: 678
|
by increased Ser9 phosphorylation
|
Drugbank entries
|
Show/Hide entries for
IGF1
or
GSK3B
|
Drugbank
DB01890
|
|
Drugbank
DB02643
|
N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propa ...
|
Drugbank
DB01890
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Endothelin-1 inhibites GSK3B through Ser-9 phosphorylation in a PI3K-dependent manner in myocytes.
|
Formal Description Interaction-ID: 679
|
in myocytes; by phosphorylation of GSK3B at Ser9
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Endothelin-1 inhibites GSK3B through Ser-9 phosphorylation in a PI3K-dependent manner in myocytes.
|
Formal Description Interaction-ID: 680
|
increases_phosphorylation of
at Ser9, hereby inhibiting GSK3B.
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Complex formation between GSK3B and proteins in the GBP family is an important mechanism for the inhibitory control of GSK3B activity.
|
Formal Description Interaction-ID: 686
|
interacts (colocalizes) with
This is an important mechanism for the inhibitory control of GSK3B activity.
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Opposite to the inhibitory effect of complex formation with GBP, GSK3B activity is enhanced by binding to Axin, which is both a substrate for phosphorylation by GSK3B and enhances GSK3B-induced phosphorylation of beta-catenin.
|
Formal Description Interaction-ID: 687
|
|
Drugbank entries
|
Show/Hide entries for
AXIN1
or
GSK3B
|
Drugbank
DB04447
|
|
Drugbank
DB04447
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
In the absence of Wnt, GSK3B is complexed with Axin and APC and phosphorylates beta-catenin, targeting it for degradation.
|
Formal Description Interaction-ID: 754
|
increases_phosphorylation of
in the absence of Wnt and if GSK3B is complexed with Axin and APC;
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
CTNNB1
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB03904
|
|
Drugbank
DB03904
|
|
|
|
Comment
|
Frat1 binds and inactivates GSK3B, blocking phosphorylation of beta-catenin.
|
Formal Description Interaction-ID: 760
|
interacts (colocalizes) with
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Frat1 binds and inactivates GSK3B, blocking phosphorylation of beta-catenin.
|
Formal Description Interaction-ID: 761
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3B phosphorylates, deactivates, and induces nuclear export of NFATc, providing a mechanism by which calcium-calcineurin signaling and GSK3B could counteract each other to regulate NFATc activity.
|
Formal Description Interaction-ID: 805
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
NFAT induces IL-2 production.
|
Formal Description Interaction-ID: 807
|
|
Drugbank entries
|
Show/Hide entries for
IL2
|
Drugbank
DB02555
|
|
Drugbank
DB02581
|
5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino- ...
|
Drugbank
DB03372
|
3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbo ...
|
Drugbank
DB03453
|
(R)-N-[2-[1-(Aminoiminomethyl)-3-Piperid ...
|
Drugbank
DB03455
|
(1h-Indol-3-Yl)-(2-Mercapto-Ethoxyimino) ...
|
Drugbank
DB03957
|
|
Drugbank
DB04278
|
2-[2-(2-Cyclohexyl-2-Guanidino-Acetylami ...
|
Drugbank
DB02555
|
|
Drugbank
DB02581
|
5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino- ...
|
Drugbank
DB03453
|
(R)-N-[2-[1-(Aminoiminomethyl)-3-Piperid ...
|
Drugbank
DB03957
|
|
Drugbank
DB04278
|
2-[2-(2-Cyclohexyl-2-Guanidino-Acetylami ...
|
|
|
Comment
|
Abeta-activated GSK3B phosphorylated and inactivated pyruvate dehydrogenase, resulting in reduced synthesis of acetylcholine due to depletion of its precursor acetyl coenzyme A.
|
Formal Description Interaction-ID: 865
|
increases_phosphorylation of
complex/PPI
Pyruvate dehydrogenase complex
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Presenilin 1 binds to GSK3B.
Mutant forms of presenilin 1 can modify the activity and function of GSK3B.
|
Formal Description Interaction-ID: 908
|
interacts (colocalizes) with
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Presenilin 1 is capable of modulating its activity by regulating Akt.
|
Formal Description Interaction-ID: 909
|
|
Drugbank entries
|
Show/Hide entries for
AKT1
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Comment
|
GSK3B facilitates apoptosis.
|
Formal Description Interaction-ID: 911
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3 activity inhibits CREB.
|
Formal Description Interaction-ID: 919
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
CREB1
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB00131
|
|
Drugbank
DB01183
|
|
Drugbank
DB00131
|
|
|
|
Comment
|
GSK3beta phosphorylates PDH, which decreases acetylcholine synthesis.
|
Formal Description Interaction-ID: 12873
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3beta is complexed with Axin and APC.
|
Formal Description Interaction-ID: 12875
|
interacts (colocalizes) with
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3beta is complexed with Axin and APC.
|
Formal Description Interaction-ID: 12876
|
interacts (colocalizes) with
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
AXIN1
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB04447
|
|
Drugbank
DB04447
|
|
|
|
Comment
|
GSK3beta can phosphorylate serine residues 38, 42, and 62, and threonine residue 58 within the transactivation domain of Myc, sites considered important for regulation of Myc transcriptional activity in vivo.
|
Formal Description Interaction-ID: 12923
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Ser-9 of GSK3beta is phosphorylated (and thus inhibited) by protein kinase A.
|
Formal Description Interaction-ID: 12925
|
if GSK3B is phosphorylated at Ser9.
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
H2O2 reduces the activity of GSK3beta.
|
Formal Description Interaction-ID: 12927
|
drug/chemical compound
H2O2
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Cell stressors can modulate the activity of GSK3beta, as both heat shock and oxidative stress can cause inhibition of GSK3beta.
|
Formal Description Interaction-ID: 12929
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Insulin-like growth factor-1 (IGF-1) inhibits GSK3B through increased Ser-9 phosphorylation in a PI3K-dependent manner.
|
Formal Description Interaction-ID: 12930
|
increases_phosphorylation of
at Ser9
|
Drugbank entries
|
Show/Hide entries for
IGF1
or
GSK3B
|
Drugbank
DB01890
|
|
Drugbank
DB02643
|
N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propa ...
|
Drugbank
DB01890
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3B phosphorylates, deactivates, and induces nuclear export of NFATc, providing a mechanism by which calcium-calcineurin signaling and GSK3B could counteract each other to regulate NFATc activity.
|
Formal Description Interaction-ID: 12947
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3B phosphorylates, deactivates, and induces nuclear export of NFATc, providing a mechanism by which calcium-calcineurin signaling and GSK3B could counteract each other to regulate NFATc activity.
|
Formal Description Interaction-ID: 12948
|
GSK3B phosphorylates, deactivates, and induces nuclear export of NFATc.
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Abeta-activated GSK3B phosphorylated and inactivated pyruvate dehydrogenase, resulting in reduced synthesis of acetylcholine due to depletion of its precursor acetyl coenzyme A.
|
Formal Description Interaction-ID: 12957
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
or
Acetylcholine
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB03128
|
|
Drugbank
DB03128
|
|
|
|
Comment
|
GSK3beta is activated by amyloid beta peptide and phosphorylates APP.
|
Formal Description Interaction-ID: 14051
|
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Insulin-like growth factor-1 (IGF-1) inhibits GSK3B through increased Ser-9 phosphorylation in a PI3K-dependent manner.
|
Formal Description Interaction-ID: 50125
|
increases_phosphorylation of
at Ser9
|
Drugbank entries
|
Show/Hide entries for
IGF1
or
GSK3B
|
Drugbank
DB01890
|
|
Drugbank
DB02643
|
N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propa ...
|
Drugbank
DB01890
|
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
Abeta-activated GSK3B phosphorylated and inactivated pyruvate dehydrogenase, resulting in reduced synthesis of acetylcholine due to depletion of its precursor acetyl coenzyme A.
|
Formal Description Interaction-ID: 72065
|
complex/PPI
Pyruvate dehydrogenase complex
via phosphorylation
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
GSK3beta phosphorylates PDH, which decreases acetylcholine synthesis.
|
Formal Description Interaction-ID: 133776
|
protein modification
PDP1-phos
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
CREB is phosphorylated by GSK3b.
|
Formal Description Interaction-ID: 153728
|
protein modification
CREB1-phos
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|
Comment
|
CREB is phosphorylated by GSK3b.
|
Formal Description Interaction-ID: 153729
|
phenotype
increased CREB1-phos level
|
Drugbank entries
|
Show/Hide entries for
GSK3B
|
Drugbank
DB01356
|
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB03444
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h) ...
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
Drugbank
DB07014
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4- ...
|
Drugbank
DB07058
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6 ...
|
Drugbank
DB07149
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluo ...
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB07676
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)- ...
|
Drugbank
DB07812
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyr ...
|
Drugbank
DB07859
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL ...
|
Drugbank
DB07947
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CH ...
|
Drugbank
DB08073
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1 ...
|
Drugbank
DB01772
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl] ...
|
Drugbank
DB01793
|
|
Drugbank
DB01950
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thia ...
|
Drugbank
DB02010
|
|
Drugbank
DB02052
|
|
Drugbank
DB03431
|
|
Drugbank
DB04014
|
|
Drugbank
DB04395
|
Phosphoaminophosphonic Acid-Adenylate Es ...
|
|
|